应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IVVD Invivyd, Inc.
休市中 12-27 16:00:00 EST
0.5100
-0.0204
-3.85%
盘后
0.5500
+0.0400
+7.84%
18:33 EST
最高
0.5600
最低
0.5029
成交量
93.96万
今开
0.5469
昨收
0.5304
日振幅
10.77%
总市值
6,100万
流通市值
2,385万
总股本
1.20亿
成交额
49.06万
换手率
2.01%
流通股本
4,677万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Invivyd, Inc.盘中异动 急速上涨5.58%报0.560美元
市场透视 · 12-27 22:43
Invivyd, Inc.盘中异动 急速上涨5.58%报0.560美元
Invivyd, Inc.盘中异动 股价大涨5.33%
市场透视 · 12-26 23:09
Invivyd, Inc.盘中异动 股价大涨5.33%
Invivyd, Inc.盘中异动 下午盘股价大涨5.18%
市场透视 · 12-24
Invivyd, Inc.盘中异动 下午盘股价大涨5.18%
Invivyd, Inc.盘中异动 早盘股价大涨5.38%报0.453美元
市场透视 · 12-20
Invivyd, Inc.盘中异动 早盘股价大涨5.38%报0.453美元
Invivyd, Inc.盘中异动 急速下挫5.00%
市场透视 · 12-19
Invivyd, Inc.盘中异动 急速下挫5.00%
Invivyd, Inc.盘中异动 早盘股价大跌6.16%
市场透视 · 12-17
Invivyd, Inc.盘中异动 早盘股价大跌6.16%
Invivyd, Inc.盘中异动 大幅上涨5.47%
市场透视 · 12-09
Invivyd, Inc.盘中异动 大幅上涨5.47%
Invivyd, Inc.盘中异动 大幅拉升6.50%
市场透视 · 12-06
Invivyd, Inc.盘中异动 大幅拉升6.50%
Invivyd, Inc.盘中异动 股价大跌5.63%
市场透视 · 12-03
Invivyd, Inc.盘中异动 股价大跌5.63%
Invivyd, Inc.盘中异动 早盘股价大涨5.01%报0.734美元
市场透视 · 12-02
Invivyd, Inc.盘中异动 早盘股价大涨5.01%报0.734美元
Invivyd, Inc.盘中异动 快速拉升5.31%报0.710美元
市场透视 · 11-29
Invivyd, Inc.盘中异动 快速拉升5.31%报0.710美元
Invivyd, Inc.盘中异动 早盘快速上涨6.29%
市场透视 · 11-27
Invivyd, Inc.盘中异动 早盘快速上涨6.29%
Invivyd, Inc.盘中异动 股价大跌5.86%报0.631美元
市场透视 · 11-27
Invivyd, Inc.盘中异动 股价大跌5.86%报0.631美元
Invivyd, Inc.盘中异动 早盘股价大涨6.93%
市场透视 · 11-25
Invivyd, Inc.盘中异动 早盘股价大涨6.93%
Invivyd, Inc.2024财年第三财季实现净利润-60.74百万美元,同比减少54.01%
市场透视 · 11-23
Invivyd, Inc.2024财年第三财季实现净利润-60.74百万美元,同比减少54.01%
Invivyd, Inc.盘中异动 临近午盘股价大涨5.20%
市场透视 · 11-20
Invivyd, Inc.盘中异动 临近午盘股价大涨5.20%
Invivyd 公司报告本季度业绩 - 收益摘要
路透中文 · 11-15
Invivyd 公司报告本季度业绩 - 收益摘要
Invivyd, Inc.盘中异动 大幅跳水5.00%报0.950美元
市场透视 · 11-13
Invivyd, Inc.盘中异动 大幅跳水5.00%报0.950美元
Invivyd Inc 预计每股亏损 34 美分 - 财报前瞻
Reuters · 11-12
Invivyd Inc 预计每股亏损 34 美分 - 财报前瞻
Invivyd, Inc.盘中异动 早盘急速跳水7.00%
市场透视 · 11-08
Invivyd, Inc.盘中异动 早盘急速跳水7.00%
加载更多
公司概况
公司名称:
Invivyd, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司,其使命是快速、永久地提供基于抗体的疗法,保护弱势群体免受传播病毒威胁的破坏性后果,首先是SARS-CoV-2。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进新的单克隆抗体(“单克隆抗体”)的快速串行生成,以跟上不断发展的病毒威胁的步伐。
发行价格:
--
{"stockData":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":0.51,"timestamp":1735333200000,"preClose":0.5304,"halted":0,"volume":939634,"hourTrading":{"tag":"盘后","latestPrice":0.55,"preClose":0.51,"latestTime":"18:33 EST","volume":11241,"amount":5973.7509,"timestamp":1735342418316},"delay":0,"floatShares":46765695,"shares":119616035,"eps":-1.938346,"marketStatus":"休市中","change":-0.0204,"latestTime":"12-27 16:00:00 EST","open":0.5469,"high":0.56,"low":0.5029,"amount":490580.3743882,"amplitude":0.107655,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.938346,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":0.5304,"preHourTrading":{"tag":"盘前","latestPrice":0.549,"preClose":0.5304,"latestTime":"09:25 EST","volume":3547,"amount":1938.882422,"timestamp":1735309500086},"postHourTrading":{"tag":"盘后","latestPrice":0.55,"preClose":0.51,"latestTime":"18:33 EST","volume":11241,"amount":5973.7509,"timestamp":1735342418316},"volumeRatio":0.6929055583856908,"impliedVol":0.7952,"impliedVolPercentile":0.4881},"requestUrl":"/m/hq/s/IVVD","defaultTab":"news","newsList":[{"id":"2494386418","title":"Invivyd, Inc.盘中异动 急速上涨5.58%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494386418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494386418?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:43","pubTimestamp":1735310637,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时43分,Invivyd, Inc.股票出现波动,股价大幅拉升5.58%。截至发稿,该股报0.560美元/股,成交量6.2983万股,换手率0.05%,振幅1.92%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227224358a20c00c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227224358a20c00c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2494869752","title":"Invivyd, Inc.盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494869752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494869752?lang=zh_cn&edition=full","pubTime":"2024-12-26 23:09","pubTimestamp":1735225772,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日23时09分,Invivyd, Inc.股票出现异动,股价急速拉升5.33%。截至发稿,该股报0.537美元/股,成交量9.1145万股,换手率0.08%,振幅4.39%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122623093298504cdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122623093298504cdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2493797761","title":"Invivyd, Inc.盘中异动 下午盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493797761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493797761?lang=zh_cn&edition=full","pubTime":"2024-12-24 03:58","pubTimestamp":1734983902,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日03时58分,Invivyd, Inc.股票出现异动,股价快速拉升5.18%。截至发稿,该股报0.467美元/股,成交量71.4558万股,换手率0.60%,振幅8.27%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为1.04%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122403582295eadfe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122403582295eadfe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2492441424","title":"Invivyd, Inc.盘中异动 早盘股价大涨5.38%报0.453美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492441424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492441424?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:31","pubTimestamp":1734705082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时31分,Invivyd, Inc.股票出现波动,股价急速上涨5.38%。截至发稿,该股报0.453美元/股,成交量11.3046万股,换手率0.09%,振幅0.00%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223123ab876470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223123ab876470&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2492584751","title":"Invivyd, Inc.盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492584751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492584751?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:38","pubTimestamp":1734550718,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时38分,Invivyd, Inc.股票出现波动,股价快速下挫5.00%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为1.67%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033838ab828525&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033838ab828525&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2492973619","title":"Invivyd, Inc.盘中异动 早盘股价大跌6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492973619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492973619?lang=zh_cn&edition=full","pubTime":"2024-12-17 00:19","pubTimestamp":1734365984,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日00时19分,Invivyd, Inc.股票出现波动,股价急速下跌6.16%。截至发稿,该股报0.513美元/股,成交量22.9374万股,换手率0.19%,振幅7.57%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217001944a1f374c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217001944a1f374c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2490775587","title":"Invivyd, Inc.盘中异动 大幅上涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490775587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490775587?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:31","pubTimestamp":1733754710,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时31分,Invivyd, Inc.股票出现波动,股价快速拉升5.47%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Metagenomi, Inc.涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为2052.30%、23.49%、18.63%,振幅较大的相关个股有Relmada Therapeutics, Inc.、Sab Biotherapeutics, Inc.、Scpharmaceuticals Inc.,振幅分别为109.29%、103.26%、102.32%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223150ab6a0999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223150ab6a0999&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2489623918","title":"Invivyd, Inc.盘中异动 大幅拉升6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489623918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489623918?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:36","pubTimestamp":1733495770,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时36分,Invivyd, Inc.股票出现波动,股价大幅拉升6.50%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Cardio Diagnostics Holdings Inc.、Nanobiotix涨幅较大,Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为26.64%、23.14%、13.21%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Entero Therapeutics Inc.,振幅分别为13.20%、12.70%、11.71%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622361398e5e1cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622361398e5e1cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2488410939","title":"Invivyd, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488410939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488410939?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:22","pubTimestamp":1733239320,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时22分,Invivyd, Inc.股票出现异动,股价大幅下跌5.63%。截至发稿,该股报0.660美元/股,成交量15.1218万股,换手率0.13%,振幅5.19%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为0.54%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120323220198e51e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120323220198e51e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2488672274","title":"Invivyd, Inc.盘中异动 早盘股价大涨5.01%报0.734美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488672274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488672274?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:36","pubTimestamp":1733150202,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时36分,Invivyd, Inc.股票出现异动,股价快速拉升5.01%。截至发稿,该股报0.734美元/股,成交量7.8336万股,换手率0.07%,振幅2.19%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223643a2669b98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223643a2669b98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2487638565","title":"Invivyd, Inc.盘中异动 快速拉升5.31%报0.710美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487638565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487638565?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:30","pubTimestamp":1732890649,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时30分,Invivyd, Inc.股票出现波动,股价大幅拉升5.31%。截至发稿,该股报0.710美元/股,成交量3.8637万股,换手率0.03%,振幅1.48%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922304998e46625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922304998e46625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2486820580","title":"Invivyd, Inc.盘中异动 早盘快速上涨6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486820580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486820580?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:32","pubTimestamp":1732717929,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时32分,Invivyd, Inc.股票出现异动,股价急速上涨6.29%。截至发稿,该股报0.627美元/股,成交量4.2491万股,换手率0.04%,振幅0.61%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223209a259f1e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223209a259f1e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2486835238","title":"Invivyd, Inc.盘中异动 股价大跌5.86%报0.631美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486835238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486835238?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:09","pubTimestamp":1732637376,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时09分,Invivyd, Inc.股票出现波动,股价大幅下挫5.86%。截至发稿,该股报0.631美元/股,成交量24.2284万股,换手率0.20%,振幅8.30%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为0.27%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112700093698e44b70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112700093698e44b70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2486203880","title":"Invivyd, Inc.盘中异动 早盘股价大涨6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486203880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486203880?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:31","pubTimestamp":1732545105,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时31分,Invivyd, Inc.股票出现异动,股价急速上涨6.93%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.92%。其相关个股中,Scholar Rock Holding Corporation、Citius Pharmaceuticals, Inc.、Bridgebio Pharma, Inc.涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为85.53%、52.08%、33.73%,振幅较大的相关个股有Nkgen Biotech, Inc.、Poseida Therapeutics, Inc.、Invizyne Technologies Inc.,振幅分别为8.86%、7.33%、6.71%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223146a2548bee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223146a2548bee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2485298733","title":"Invivyd, Inc.2024财年第三财季实现净利润-60.74百万美元,同比减少54.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298733?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291352,"startTime":"0","endTime":"0","summary":"11月23日,Invivyd, Inc.公布财报,公告显示公司2024财年第三财季净利润为-60.74百万美元,同比减少54.01%;其中营业收入为9.30百万美元,每股基本收益为-0.51美元。从资产负债表来看,Invivyd, Inc.总负债78.76百万美元,其中短期债务1.41百万美元,资产负债比为0.03,流动比率为0.02。机构评级:截至2024年11月23日,当前有5家机构对Invivyd, Inc.目标价做出预测,其中目标均价为6.51美元,其中最低目标价为1.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000259a24e496d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000259a24e496d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD"],"gpt_icon":1},{"id":"2484927951","title":"Invivyd, Inc.盘中异动 临近午盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484927951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484927951?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:42","pubTimestamp":1732034529,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时42分,Invivyd, Inc.股票出现异动,股价急速拉升5.20%。Invivyd, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大,Tff Pharmaceuticals, Inc.、Syros Pharmaceuticals, Inc.、Exicure, Inc.较为活跃,换手率分别为813.25%、334.51%、123.17%,振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为91.10%、81.67%、62.18%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120004210971a77c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120004210971a77c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2483332130","title":"Invivyd 公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332130","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332130?lang=zh_cn&edition=full","pubTime":"2024-11-15 05:00","pubTimestamp":1731618000,"startTime":"0","endTime":"0","summary":"Invivyd 公司报告本季度业绩 - 收益摘要Invivyd Inc IVVD.OQ报告本季度调整后每股亏损51美分,低于去年同期的每股收益-36美分。四位分析师对该季度的平均预期是每股亏损 34 美分。Invivyd Inc公布的本季度每股收益为亏损51美分。该公司当季亏损 6,074 万美元。Invivyd Inc本季度股价下跌了12.7%,今年迄今为止亏损了77.4%。华尔街对 Invivyd 公司 12 个月目标价的中位数为 9.00 本摘要由 LSEG 11 月 14 日 08:59 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML1WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2483882445","title":"Invivyd, Inc.盘中异动 大幅跳水5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882445?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:48","pubTimestamp":1731509306,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时48分,Invivyd, Inc.股票出现异动,股价急速跳水5.00%。截至发稿,该股报0.950美元/股,成交量4.308万股,换手率0.04%,振幅3.46%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224826abbde5d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224826abbde5d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2482707100","title":"Invivyd Inc 预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482707100","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482707100?lang=zh_cn&edition=full","pubTime":"2024-11-12 21:54","pubTimestamp":1731419683,"startTime":"0","endTime":"0","summary":" * Invivyd Inc 将于11月14日公布截至2024年9月30日的财报,预计季度收入将有所增长。* 根据LSEG的数据,4位分析师的平均预期显示,这家总部位于马萨诸塞州沃尔瑟姆的公司预计将实现2725万美元的营收。* LSEG 分析师对 Invivyd 公司的平均预期是每股亏损 34 美分。* 华尔街对 Invivyd Inc 的 12 个月目标价中位数为 9.00 美元,高于其最新收盘价 0.98 美元。11月12日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Invivyd Inc 预计每股亏损 34 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD"],"gpt_icon":0},{"id":"2481309100","title":"Invivyd, Inc.盘中异动 早盘急速跳水7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481309100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481309100?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:09","pubTimestamp":1731078553,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时09分,Invivyd, Inc.股票出现波动,股价急速下挫7.00%。Invivyd, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。Invivyd, Inc.公司简介:Invivyd Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823091398e4181a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823091398e4181a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.invivyd.com","stockEarnings":[{"period":"1week","weight":0.1489},{"period":"1month","weight":-0.2435},{"period":"3month","weight":-0.5565},{"period":"6month","weight":-0.5364},{"period":"1year","weight":-0.8699},{"period":"ytd","weight":-0.8706}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司,其使命是快速、永久地提供基于抗体的疗法,保护弱势群体免受传播病毒威胁的破坏性后果,首先是SARS-CoV-2。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进新的单克隆抗体(“单克隆抗体”)的快速串行生成,以跟上不断发展的病毒威胁的步伐。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.23988},{"month":2,"riseRate":0,"avgChangeRate":-0.160396},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.16632},{"month":4,"riseRate":0,"avgChangeRate":-0.318713},{"month":5,"riseRate":0.666667,"avgChangeRate":0.166719},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.236911},{"month":7,"riseRate":1,"avgChangeRate":0.206353},{"month":8,"riseRate":0.666667,"avgChangeRate":0.077457},{"month":9,"riseRate":0.5,"avgChangeRate":0.012082},{"month":10,"riseRate":0.25,"avgChangeRate":-0.060343},{"month":11,"riseRate":0.25,"avgChangeRate":-0.016998},{"month":12,"riseRate":0.25,"avgChangeRate":0.030812}],"exchange":"NASDAQ","name":"Invivyd, Inc.","nameEN":"Invivyd, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Invivyd, Inc.,IVVD,Invivyd, Inc.股票,Invivyd, Inc.股票老虎,Invivyd, Inc.股票老虎国际,Invivyd, Inc.行情,Invivyd, Inc.股票行情,Invivyd, Inc.股价,Invivyd, Inc.股市,Invivyd, Inc.股票价格,Invivyd, Inc.股票交易,Invivyd, Inc.股票购买,Invivyd, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}